FABIANI, COSTANZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.018
EU - Europa 881
AS - Asia 240
AF - Africa 6
Totale 2.145
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.015
RU - Federazione Russa 451
IE - Irlanda 101
SE - Svezia 96
IT - Italia 93
PL - Polonia 66
SG - Singapore 66
HK - Hong Kong 59
JO - Giordania 47
CN - Cina 42
CH - Svizzera 35
DE - Germania 17
IN - India 15
FI - Finlandia 14
VN - Vietnam 8
CI - Costa d'Avorio 6
GB - Regno Unito 6
CA - Canada 3
TR - Turchia 2
NL - Olanda 1
TJ - Tagikistan 1
UA - Ucraina 1
Totale 2.145
Salva come PNG Salva come JPEG
Città #
Santa Clara 260
Dublin 101
Fairfield 96
Chandler 92
Warsaw 66
Singapore 56
Altamura 53
Lawrence 52
Woodbridge 45
Hong Kong 40
Ashburn 38
Wilmington 36
Bern 34
Houston 29
Seattle 29
Moscow 28
Princeton 26
Cambridge 25
Boston 23
Buffalo 19
Mumbai 15
Lappeenranta 14
Shanghai 13
Ann Arbor 10
Boardman 10
Florence 10
Dong Ket 8
Kent 8
Beijing 7
San Diego 7
Abidjan 6
Medford 6
New York 6
Rome 5
Falls Church 4
Redwood City 4
Yubileyny 4
Andover 3
Guangzhou 3
Los Angeles 3
Padova 3
Rieti 3
San Giustino 3
Taizhou 3
Toronto 3
Andria 2
Capannori 2
Hillsboro 2
London 2
Trumbull 2
Wernigerode 2
Bad Kreuznach 1
Chiswick 1
Council Bluffs 1
Esslingen am Neckar 1
Gorizia 1
Hangzhou 1
Hanover 1
Irkutsk 1
Kilburn 1
Leawood 1
Milan 1
Monmouth Junction 1
Munich 1
Naaldwijk 1
Nanjing 1
New Bedfont 1
Norwalk 1
Philadelphia 1
Prescot 1
Redmond 1
Sedriano 1
Washington 1
Totale 1.343
Salva come PNG Salva come JPEG
Nome #
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 139
Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017 132
Perioperative dental screening and treatment in patients undergoing cardiothoracic surgery and interventional cardiovascular procedures. A consensus report based on RAND/UCLA methodology 108
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 96
The Presence of Uveitis Is Associated With a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 95
New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy 95
Perioperative dental screening and treatment in patients undergoing cardio-thoracic surgery and interventional cardiovascular procedures. A consensus report based on RAND/UCLA methodology 93
Long-term Retention Rates of Adalimumab and Infliximab in Non-Infectious Intermediate, Posterior, and Panuveitis 87
Predictors of Sustained Clinical Response in Patients With Behçet's Disease-Related Uveitis Treated With Infliximab and Adalimumab 86
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease 83
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 83
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 82
Ventilation and outcomes following robotic-assisted abdominal surgery: an international, multicentre observational study 80
FRI0586 Interleukin (IL)-1 inhibition with anakinra and canakinumab in behÇet's disease related uveitis: a multicenter retrospective observational study 80
THU0540 Efficacy and safety of adalimumab in behÇet's disease related uveitis: a multicenter retrospective observational study 79
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 75
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis 74
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease 73
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 70
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 69
Clinical profile and evolution of patients with juvenile-onset Behçet’s syndrome over a 25-year period: insights from the AIDA network 67
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis 66
Prompt Clinical Response to Secukinumab in Patients With Axial Spondyloarthritis: Real Life Observational Data From Three Italian Referral Centers 66
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 61
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: Observational study from the International AIDA Registry 60
The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors 49
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis 36
Totale 2.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.697
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202097 0 0 0 0 3 6 9 8 11 10 16 34
2020/2021269 16 21 17 16 40 15 41 19 28 24 10 22
2021/2022155 2 2 6 5 2 11 0 20 7 9 26 65
2022/2023573 48 156 20 11 19 85 57 39 74 5 21 38
2023/2024210 7 16 28 11 13 20 9 51 6 27 14 8
2024/2025870 53 148 92 270 307 0 0 0 0 0 0 0
Totale 2.184